AIDS News and Research

RSS
One-third of U.S. adults use some form of alternative medicine

One-third of U.S. adults use some form of alternative medicine

Adolescents take that first step in halting the growing rates of HIV, AIDS and sexually transmitted diseases

Adolescents take that first step in halting the growing rates of HIV, AIDS and sexually transmitted diseases

A protein that the body uses to attack the AIDS virus is actually a stealthy defense mechanism that evolved 32 million years before HIV

A protein that the body uses to attack the AIDS virus is actually a stealthy defense mechanism that evolved 32 million years before HIV

Mining giant Rio Tinto has developed and implemented a global HIV/AIDS strategy

Mining giant Rio Tinto has developed and implemented a global HIV/AIDS strategy

Inexpensive generic three-in-one fixed-dose combination pill taken twice a day has helped HIV/AIDS patients in Uganda

Inexpensive generic three-in-one fixed-dose combination pill taken twice a day has helped HIV/AIDS patients in Uganda

Researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS

Researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS

Risk of pelvic inflammatory disease (PID) decreases with condom use

Risk of pelvic inflammatory disease (PID) decreases with condom use

Australian Commonwealth and Queensland Governments sign public health funding agreement

Australian Commonwealth and Queensland Governments sign public health funding agreement

Drug to fight virus from the herpes family in transplant patients moves forward in trials

Drug to fight virus from the herpes family in transplant patients moves forward in trials

Molecular pathway in the brain may explain why some patients suffering from inflammatory diseases develop depression

Molecular pathway in the brain may explain why some patients suffering from inflammatory diseases develop depression

Diseases are being neglected in wake of HIV/AIDS, TB and Malaria

Diseases are being neglected in wake of HIV/AIDS, TB and Malaria

Study shows safe, effective therapy for previously untreated patients with HIV & hepatitis C

Study shows safe, effective therapy for previously untreated patients with HIV & hepatitis C

Study examines socio-economic impact of HIV/AIDS on people living with HIV/AIDS and their families in India

Study examines socio-economic impact of HIV/AIDS on people living with HIV/AIDS and their families in India

PAHO and UNICEF to work jointly in disasters, immunization campaigns, prevention of HIV, and monitoring nutrition

PAHO and UNICEF to work jointly in disasters, immunization campaigns, prevention of HIV, and monitoring nutrition

British Government needs to get its act together to tackle the soaring rates of sexually transmitted infections

British Government needs to get its act together to tackle the soaring rates of sexually transmitted infections

Latin America still not faced a large-scale AIDS epidemic

Latin America still not faced a large-scale AIDS epidemic

GlaxoSmithKline to stand trial on AIDS drugs

GlaxoSmithKline to stand trial on AIDS drugs

European scientists expect to begin human trials using pharmaceuticals grown in GM plants

European scientists expect to begin human trials using pharmaceuticals grown in GM plants

Malaria mortality rate in Africa and Asia could double in a few decades as the drug used most frequently is rendered useless

Malaria mortality rate in Africa and Asia could double in a few decades as the drug used most frequently is rendered useless

New DNA microarray to speed bone disease research

New DNA microarray to speed bone disease research

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.